MENU
ALLO
AS OF
Nov 13, 04:59 PM (EDT)
Price
$1.20
Change
-$0.03 (-2.44%)
Capitalization
274.17M
111 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
ALLO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Allogene Therapeutics (ALLO) Earnings Date & Reports

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

ALLO is expected to report earnings to rise 16.11% to -22 cents per share on March 04

Allogene Therapeutics ALLO Stock Earnings Reports
Q4'25
Est.
$-0.22
Q3'25
Beat
by $0.03
Q2'25
Beat
by $0.04
Q1'25
Beat
by $0.01
Q4'24
Beat
by $0.04
The last earnings report on November 06 showed earnings per share of -18 cents, beating the estimate of -21 cents. With 1.02M shares outstanding, the current market capitalization sits at 274.17M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
ALLO
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ALLO showed earnings on November 06, 2025. You can read more about the earnings report here.
View AI-Driven Trading for ALLO
A.I. Advisor
published General Information

General Information

a developer of allogeneic chimeric antigen receptor therapy

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
210 East Grand Avenue
Phone
+1 650 457-2700
Employees
233
Web
https://www.allogene.com